EDVA (EDVA) Stock Price, News & Analysis
EDVA
Why is EDVA Stock Up Today?
5.65%
25 alerts
15m delay
Company Description
For FY2025, EDVA reported revenue of $73K and diluted earnings per share of -$11.97.
This page collects what Stock Titan holds for EDVA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$0.4072
-
-
Last updated: August 25, 2026 at 12:01
-
Performance 1 year
EDVA Rankings
Revenue
$73.1K
#3,455
Piotroski F-Score
2/9
#6,107
Latest News
EDVA has 1 recent news article, with the latest published today. View all EDVA news →
SEC Filings
Financial Highlights
EDVA generated $73K in revenue in FY2025, retaining a 23.1% gross margin. Diluted earnings per share stood at -$11.97. The company generated -$4.8M in operating cash flow. With a current ratio of 0.04, short-term liquidity bears monitoring.
$73K
Revenue (FY2025)
-$11.97
-$4.8M
Operating Cash Flow
23.1%
0.04
$17K
Gross Profit (FY2025)
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
Frequently Asked Questions
What is the revenue of EDVA (EDVA) stock?
The FY2025 revenue of EDVA (EDVA) is $73K, from its most recent completed fiscal year.
What is the operating cash flow of EDVA (EDVA)?
The operating cash flow of EDVA (EDVA) is -$4.8M. Learn about cash flow.
What is the gross margin of EDVA (EDVA)?
The gross profit margin of EDVA (EDVA) is 23.1%. Learn about gross margins.
What is the current ratio of EDVA (EDVA)?
The current ratio of EDVA (EDVA) is 0.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of EDVA (EDVA)?
The gross profit of EDVA (EDVA) is $17K for FY2025, its most recent completed fiscal year.
The first FDA regulatory milestone announced by Endovia Health Sciences for its CannEpil® veterinary development program is a plausible catalyst for today’s move, but the announcement does not establish that it caused the trading.